Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy

Placenta

Volumn 34, Issue 12, 2013, Pages 1170-1176

  Zamudio, S ^a   Kovalenko, O ^b   Echalar, L ^c   Torricos, T ^d   Al Khan, A ^a   Alvarez, M ^a   Illsley, N P ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD MAYOR DE SAN ANDRÉS   (Bolivia)

^d Hospital Hernandez Vera   (Bolivia)

Author keywords

Monocytes; PlGF; sFlt 1; VEGF platelets

Indexed keywords

ADENOSINE; ANGIOGENIC FACTOR; CITRATE SODIUM; DIPYRIDAMOLE; PLACENTAL GROWTH FACTOR; PROTEIN SFLT 1; PROTEIN TYROSINE KINASE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; UMBILICAL CORD;

MONOCYTES; PLGF; SFLT-1; VEGF PLATELETS;

ADULT; ANGIOGENIC PROTEINS; ANTICOAGULANTS; BLOOD SPECIMEN COLLECTION; CESAREAN SECTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; LIMIT OF DETECTION; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTATION; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY PROTEINS; REPRODUCIBILITY OF RESULTS; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84888343205     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2013.09.016     Document Type: Article

References (53)

1. F. Lyall, A. Young, F. Boswell, J.C. Kingdom, and I.A. Greer Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery Placenta 18 4 1997 269 276
2. P. Vuorela, S. Helske, C. Hornig, K. Alitalo, H. Weich, and E. Halmesmaki Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia Obstet Gynecol 95 3 2000 353 357
3. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 649 658
4. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 672 683
5. S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, and Y.M. Kim Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 6 2006 642 649
6. C.K. Goldman, R.L. Kendall, G. Cabrera, L. Soroceanu, Y. Heike, and G.Y. Gillespie Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate Proc Natl Acad Sci U S A 95 15 1998 8795 8800
7. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, and M.K. McLaughlin Preeclampsia: an endothelial cell disorder [see comments] Am J Obstet Gynecol 161 5 1989 1200 1204
8. I. Caniggia, J. Winter, S.J. Lye, and M. Post Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia Placenta 21 Suppl. A 2000 S25 S30
9. A. Rajakumar, K. Doty, A. Daftary, G. Harger, and K.P. Conrad Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae Placenta 24 2-3 2003 199 208
10. N. Soleymanlou, I. Jurisica, O. Nevo, F. Ietta, X. Zhang, and S. Zamudio Molecular evidence of placental hypoxia in preeclampsia J Clin Endocrinol Metab 90 7 2005 4299 4308
11. S. Zamudio, Y. Wu, F. Ietta, A. Rolfo, A. Cross, and T. Wheeler Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo Am J Pathol 170 6 2007 2171 2179
12. A. Ahmed, C. Dunk, S. Ahmad, and A. Khaliq Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-a review Placenta 21 Suppl. A 2000 S16 S24
13. G.E. Lash, C.M. Taylor, A.J. Trew, S. Cooper, F.W. Anthony, and T. Wheeler Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions Growth Factors 20 4 2002 189 196
14. H. Li, B. Gu, Y. Zhang, D.F. Lewis, and Y. Wang Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta Placenta 26 2-3 2005 210 217
15. O. Nevo, N. Soleymanlou, Y. Wu, J. Xu, J. Kingdom, and A. Many Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1 Am J Physiol Regul Integr Comp Physiol 291 4 2006 R1085 R1093
16. O. Nevo, A. Many, J. Xu, J. Kingdom, E. Piccoli, and S. Zamudio Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction J Clin Endocrinol Metab 93 1 2008 285 292
17. Y. Yinon, O. Nevo, J. Xu, A. Many, A. Rolfo, and T. Todros Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3 Am J Pathol 172 1 2008 77 85
18. J.P. Kusanovic, R. Romero, T. Chaiworapongsa, O. Erez, P. Mittal, and E. Vaisbuch A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 11 2009 1021 1038
19. A. Rajakumar, H.M. Michael, P.A. Rajakumar, E. Shibata, C.A. Hubel, and S.A. Karumanchi Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women Placenta 26 7 2005 563 573
20. A. Sawano, S. Iwai, Y. Sakurai, M. Ito, K. Shitara, and T. Nakahata Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans Blood 97 3 2001 785 791
21. S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2 J Cell Sci 116 Pt 4 2003 665 674
22. T. Lowin, C. Weidler, Z. Jenei-Lanzl, S. Capellino, C.G. Baerwald, and F. Buttgereit Relationship between placenta growth factor 1 and vascularization, dehydroepiandrosterone sulfate to dehydroepiandrosterone conversion, or aromatase expression in patients with rheumatoid arthritis and patients with osteoarthritis Arthritis Rheum 64 6 2012 1799 1808
23. M. Dewerchin, and P. Carmeliet PlGF: a multitasking cytokine with disease-restricted activity Cold Spring Harb Perspect Med 2 8 2012
24. P.N. Baker, J. Krasnow, J.M. Roberts, and K.T. Yeo Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia Obstet Gynecol 86 5 1995 815 821
25. M.J. Kupferminc, Y. Daniel, T. Englender, A. Baram, A. Many, and A.J. Jaffa Vascular endothelial growth factor is increased in patients with preeclampsia Am J Reprod Immunol 38 4 1997 302 306
26. N.J. Webb, M.J. Bottomley, C.J. Watson, and P.E. Brenchley Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease Clin Sci (Lond) 94 4 1998 395 404
27. W. Jelkmann Pitfalls in the measurement of circulating vascular endothelial growth factor Clin Chem 47 4 2001 617 623
28. G. Ogge, R. Romero, J.P. Kusanovic, T. Chaiworapongsa, Z. Dong, and P. Mittal Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice J Matern Fetal Neonatal Med 23 8 2010 820 827
29. W. Wynendaele, R. Derua, M.F. Hoylaerts, A. Pawinski, E. Waelkens, and E.A. de Bruijn Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 10 8 1999 965 971
30. R. Dittadi, S. Meo, F. Fabris, G. Gasparini, D. Contri, and M. Medici Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments Int J Biol Markers 16 2 2001 87 96
31. P. Starlinger, L. Alidzanovic, D. Schauer, P. Brugger, S. Sommerfeldt, and I. Kuehrer Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts Dis Markers 31 2 2011 55 65
32. S. Zamudio, L. Postigo, N.P. Illsley, C. Rodriguez, G. Heredia, and M. Brimacombe Maternal oxygen delivery is not related to altitude- and ancestry-associated differences in human fetal growth J Physiol 582 Pt 2 2007 883 895
33. L. Postigo, G. Heredia, N.P. Illsley, T. Torricos, C. Dolan, and L. Echalar Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude J Physiol 587 Pt 3 2009 693 708
34. S.K. Nadar, I. Karalis, E. Al Yemeni, A.D. Blann, and G.Y. Lip Plasma markers of angiogenesis in pregnancy induced hypertension Thromb Haemost 94 5 2005 1071 1076
35. G.S. Di Marco, S. Reuter, U. Hillebrand, S. Amler, M. Konig, and E. Larger The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD J Am Soc Nephrol 20 10 2009 2235 2245
36. K.A. Mohammed, N. Nasreen, R.S. Tepper, and V.B. Antony Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release Am J Physiol Lung Cell Mol Physiol 292 2 2007 L559 L566
37. M.J. Bottomley, N.J. Webb, C.J. Watson, L. Holt, M. Bukhari, and J. Denton Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid Clin Exp Immunol 119 1 2000 182 188
38. A. Rajakumar, R.W. Powers, C.A. Hubel, E. Shibata, F. von Versen-Hoynck, and D. Plymire Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women Placenta 30 1 2009 25 34
39. C.P. Thomas, J.I. Andrews, N.S. Raikwar, E.A. Kelley, F. Herse, and R. Dechend A recently evolved novel trophoblast-enriched sFlt1 variant is upregulated in hypoxia and in preeclampsia J Clin Endocrinol Metab 2009
40. P.N. Tsao, S.C. Wei, Y.N. Su, H.C. Chou, C.Y. Chen, and W.S. Hsieh Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers Pediatrics 116 2 2005 468 472
41. W. Wallner, R. Sengenberger, R. Strick, P.L. Strissel, B. Meurer, and M.W. Beckmann Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction Clin Sci (Lond) 112 1 2007 51 57
42. G. Galazios, D. Papazoglou, K. Giagloglou, G. Vassaras, N. Koutlaki, and E. Maltezos Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia Int J Gynaecol Obstet 85 1 2004 6 11
43. M. Wolf, C.A. Hubel, C. Lam, M. Sampson, J.L. Ecker, and R.B. Ness Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance J Clin Endocrinol Metab 89 12 2004 6239 6243
44. S. Muttukrishna, M. Swer, S. Suri, A. Jamil, J. Calleja-Agius, and S. Gangooly Soluble Flt-1 and PlGF: new markers of early pregnancy loss? PLoS One 6 3 2011 e18041
45. S. Rana, C.E. Powe, S. Salahuddin, S. Verlohren, F.H. Perschel, and R.J. Levine Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 7 2012 911 919
46. S. Verlohren, I. Herraiz, O. Lapaire, D. Schlembach, M. Moertl, and H. Zeisler The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients Am J Obstet Gynecol 206 1 2012 58e1 58e8
47. M. Noori, A.E. Donald, A. Angelakopoulou, A.D. Hingorani, and D.J. Williams Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension Circulation 122 5 2010 478 487
48. I.P. Gaugler-Senden, J.T. Tamsma, C. van der Bent, R. Kusters, E.A. Steegers, and C.J. de Groot Angiogenic factors in women ten years after severe very early onset preeclampsia PLoS One 7 8 2012 e43637
49. M.G. Macey, S. Bevan, S. Alam, L. Verghese, S. Agrawal, and S. Beski Platelet activation and endogenous thrombin potential in pre-eclampsia Thromb Res 125 3 2010 e76 e81
50. P. Jaremo, T.L. Lindahl, C. Lennmarken, and H. Forsgren The use of platelet density and volume measurements to estimate the severity of pre-eclampsia Eur J Clin Invest 30 12 2000 1113 1118
51. M.C. Valera, O. Parant, C. Vayssiere, J.F. Arnal, and B. Payrastre Physiologic and pathologic changes of platelets in pregnancy Platelets 21 8 2010 587 595
52. S. Lurie, E. Frenkel, and Y. Tuvbin Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy Gynecol Obstet Invest 45 4 1998 229 231
53. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 1 2003 177 182